GSK boasts win for depemokimab in asthma trials
GSK hopes that it will receive a regulatory decision on depemokimab in 2025.
GSK hopes that it will receive a regulatory decision on depemokimab in 2025.
Heartbeam AI plus VCG outperformed an expert panel of three cardiologists by 40% in detecting atrial flutter.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
UK clinical trials industry tackles recent changes in the sector
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Allucent receives grant for decentralised Covid-19 vaccine trial
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis